BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 34237281)

  • 1. Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
    Neveling K; Mantere T; Vermeulen S; Oorsprong M; van Beek R; Kater-Baats E; Pauper M; van der Zande G; Smeets D; Weghuis DO; Stevens-Kroef MJPL; Hoischen A
    Am J Hum Genet; 2021 Aug; 108(8):1423-1435. PubMed ID: 34237281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical genome mapping enables constitutional chromosomal aberration detection.
    Mantere T; Neveling K; Pebrel-Richard C; Benoist M; van der Zande G; Kater-Baats E; Baatout I; van Beek R; Yammine T; Oorsprong M; Hsoumi F; Olde-Weghuis D; Majdali W; Vermeulen S; Pauper M; Lebbar A; Stevens-Kroef M; Sanlaville D; Dupont JM; Smeets D; Hoischen A; Schluth-Bolard C; El Khattabi L
    Am J Hum Genet; 2021 Aug; 108(8):1409-1422. PubMed ID: 34237280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia.
    Valkama A; Vorimo S; Kumpula TA; Räsänen H; Savolainen ER; Pylkäs K; Mantere T
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Validation and Diagnostic Utility of Optical Genome Mapping in Prenatal Diagnostic Testing.
    Sahajpal NS; Mondal AK; Fee T; Hilton B; Layman L; Hastie AR; Chaubey A; DuPont BR; Kolhe R
    J Mol Diagn; 2023 Apr; 25(4):234-246. PubMed ID: 36758723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical Genome Mapping as a Next-Generation Cytogenomic Tool for Detection of Structural and Copy Number Variations for Prenatal Genomic Analyses.
    Sahajpal NS; Barseghyan H; Kolhe R; Hastie A; Chaubey A
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33799648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Optical Genome Mapping With Conventional Diagnostic Methods for Structural Variant Detection in Hematologic Malignancies.
    Shim Y; Koo YK; Shin S; Lee ST; Lee KA; Choi JR
    Ann Lab Med; 2024 Jul; 44(4):324-334. PubMed ID: 38433573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation.
    Levy B; Baughn LB; Akkari Y; Chartrand S; LaBarge B; Claxton D; Lennon PA; Cujar C; Kolhe R; Kroeger K; Pitel B; Sahajpal N; Sathanoori M; Vlad G; Zhang L; Fang M; Kanagal-Shamanna R; Broach JR
    Blood Adv; 2023 Apr; 7(7):1297-1307. PubMed ID: 36417763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics.
    Dai P; Zhu X; Pei Y; Chen P; Li J; Gao Z; Liang Y; Kong X
    Mol Genet Genomic Med; 2022 Jun; 10(6):e1936. PubMed ID: 35384386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
    Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
    Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements.
    Coccaro N; Zagaria A; Anelli L; Tarantini F; Tota G; Conserva MR; Cumbo C; Parciante E; Redavid I; Ingravallo G; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological Neoplasms.
    Sahajpal NS; Mondal AK; Tvrdik T; Hauenstein J; Shi H; Deeb KK; Saxe D; Hastie AR; Chaubey A; Savage NM; Kota V; Kolhe R
    J Mol Diagn; 2022 Dec; 24(12):1279-1291. PubMed ID: 36265723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA.
    Coccaro N; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Minervini CF; Minervini A; Conserva MR; Redavid I; Parciante E; Macchia MG; Specchia G; Musto P; Albano F
    Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of complex chromosome rearrangements using optical genome mapping.
    Qu J; Li S; Yu D
    Gene; 2023 Oct; 884():147688. PubMed ID: 37543218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Benchmarking of Optical Genome Mapping and Chromosomal Microarray Reveals High Technological Concordance in CNV Identification and Additional Structural Variant Refinement.
    Barseghyan H; Pang AWC; Clifford B; Serrano MA; Chaubey A; Hastie AR
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping.
    Rack K; De Bie J; Ameye G; Gielen O; Demeyer S; Cools J; De Keersmaecker K; Vermeesch JR; Maertens J; Segers H; Michaux L; Dewaele B
    Am J Hematol; 2022 May; 97(5):548-561. PubMed ID: 35119131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical genome mapping for structural variation analysis in hematologic malignancies.
    Smith AC; Neveling K; Kanagal-Shamanna R
    Am J Hematol; 2022 Jul; 97(7):975-982. PubMed ID: 35560245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical Genome Mapping as a New Tool to Overcome Conventional Cytogenetics Limitations in Patients with Bone Marrow Failure.
    Iriondo J; Gómez A; Zubicaray J; Garcia-Martinez J; Abad L; Matesanz C; Giménez R; Galán A; Sanz A; Sebastián E; González de Pablo J; de la Cruz A; Ramírez M; Sevilla J
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
    Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
    Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical Genome Mapping: A Revolutionary Tool for "Next Generation Cytogenomics Analysis" with a Broad Range of Diagnostic Applications in Human Diseases.
    Garcia-Heras J
    J Assoc Genet Technol; 2021; 47(4):191-200. PubMed ID: 34897113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytic Validation of Optical Genome Mapping in Hematological Malignancies.
    Pang AWC; Kosco K; Sahajpal NS; Sridhar A; Hauenstein J; Clifford B; Estabrook J; Chitsazan AD; Sahoo T; Iqbal A; Kolhe R; Raca G; Hastie AR; Chaubey A
    Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.